Dr Patsie Polly

Research Scientist
Medicine, Concord Clinical School
ANZAC Research Institute

Telephone 02 93852924
Fax 02 93851389

Map

Selected grants

2005

  • Repression of hepatic drug metabolism by solid tumours; Robertson G, Clarke S, Polly P, Liddle C; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Dobson-Stone, C., Polly, P., Korgaonkar, M., Williams, L., Gordon, E., Schofield, P., Mather, K., Armstrong, N., Wen, W., Sachdev, P., et al (2013). GSK3B and MAPT polymorphisms are associated with grey matter and intracranial volume in healthy individuals. PloS One, 8(8), 1-7. [More Information]
  • Shum, A., Polly, P. (2012). Cancer Cachexia: Molecular Targets and Pathways for Diagnosis and Drug Intervention. Endocrine, Metabolic & Immune Disorders - Drug Targets, 12(3), 247-259. [More Information]
  • Shum, A., Mahendradatta, T., Taylor, R., Painter, A., Moore, M., Tsoli, M., Tan, T., Clarke, S., Robertson, G., Polly, P. (2012). Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wasting. Aging, 4(2), 133-143. [More Information]
  • Morrison, N., Stephens, A., Osato, M., Polly, P., Tan, T., Yamashita, N., Doecke, J., Pasco, J., Fozzard, N., Jones, G., Sambrook, P., et al (2012). Glutamine repeat variants in human RUNX2 associated with decreased femoral neck BMD, broadband ultrasound attenuation and target gene transactivation. PloS One, 7(8), 1-11. [More Information]
  • Matic, M., Carradin, A., Tsoli, M., Clarke, S., Polly, P., Robertson, G. (2010). The alternatively spliced murine pregnane X receptor isoform, mPXRΔ171–211 exhibits a repressive action. The International Journal of Biochemistry and Cell Biology, 42(5), 672-682. [More Information]
  • Matic, M., Nakhel, S., Lehnert, A., Polly, P., Clarke, S., Robertson, G. (2009). A novel approach to investigate the subcellular distribution of nuclear receptors in vivo. Nuclear Receptor Signaling, 7(-), 1-7. [More Information]
  • Brewer, M., Changi, F., Antonellis, A., Fischbeck, K., Polly, P., Nicholson, G., Kennerson, M. (2008). Evidence of a founder haplotype refines the X-linked Charcot–Marie-Tooth (CMTX3) locus to a 2.5 Mb region. Neurogenetics, 9, 191-195. [More Information]
  • Matic, M., Mahns, A., Tsoli, M., Corradin, A., Polly, P., Robertson, G. (2006). Pregnane X Receptor: Promiscuous regulator of detoxification pathways. The International Journal of Biochemistry and Cell Biology, 39, 478-483. [More Information]
  • Polly, P., Haddadi, L., Issa, L., Subramaniam, N., Palmer, S., Tay, E., Hardeman, E. (2003). hMusTRD1α1 represses MEF2 activation of the Troponin I slow enhancer. Journal of Biological Chemistry, 278(38), 36603-36619.
  • Tay, E., Guven, K., Subramaniam, N., Polly, P., Issa, L., Gunning, P., Hardeman, E. (2003). Regulation of alternative splicing of Gtf2ird1 and its impact on slow muscle proomoter activity. Biochemical Journal, 374(2), 359-367.

2013

  • Dobson-Stone, C., Polly, P., Korgaonkar, M., Williams, L., Gordon, E., Schofield, P., Mather, K., Armstrong, N., Wen, W., Sachdev, P., et al (2013). GSK3B and MAPT polymorphisms are associated with grey matter and intracranial volume in healthy individuals. PloS One, 8(8), 1-7. [More Information]

2012

  • Shum, A., Polly, P. (2012). Cancer Cachexia: Molecular Targets and Pathways for Diagnosis and Drug Intervention. Endocrine, Metabolic & Immune Disorders - Drug Targets, 12(3), 247-259. [More Information]
  • Shum, A., Mahendradatta, T., Taylor, R., Painter, A., Moore, M., Tsoli, M., Tan, T., Clarke, S., Robertson, G., Polly, P. (2012). Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wasting. Aging, 4(2), 133-143. [More Information]
  • Morrison, N., Stephens, A., Osato, M., Polly, P., Tan, T., Yamashita, N., Doecke, J., Pasco, J., Fozzard, N., Jones, G., Sambrook, P., et al (2012). Glutamine repeat variants in human RUNX2 associated with decreased femoral neck BMD, broadband ultrasound attenuation and target gene transactivation. PloS One, 7(8), 1-11. [More Information]

2010

  • Matic, M., Carradin, A., Tsoli, M., Clarke, S., Polly, P., Robertson, G. (2010). The alternatively spliced murine pregnane X receptor isoform, mPXRΔ171–211 exhibits a repressive action. The International Journal of Biochemistry and Cell Biology, 42(5), 672-682. [More Information]

2009

  • Matic, M., Nakhel, S., Lehnert, A., Polly, P., Clarke, S., Robertson, G. (2009). A novel approach to investigate the subcellular distribution of nuclear receptors in vivo. Nuclear Receptor Signaling, 7(-), 1-7. [More Information]

2008

  • Brewer, M., Changi, F., Antonellis, A., Fischbeck, K., Polly, P., Nicholson, G., Kennerson, M. (2008). Evidence of a founder haplotype refines the X-linked Charcot–Marie-Tooth (CMTX3) locus to a 2.5 Mb region. Neurogenetics, 9, 191-195. [More Information]

2006

  • Matic, M., Mahns, A., Tsoli, M., Corradin, A., Polly, P., Robertson, G. (2006). Pregnane X Receptor: Promiscuous regulator of detoxification pathways. The International Journal of Biochemistry and Cell Biology, 39, 478-483. [More Information]

2003

  • Polly, P., Haddadi, L., Issa, L., Subramaniam, N., Palmer, S., Tay, E., Hardeman, E. (2003). hMusTRD1α1 represses MEF2 activation of the Troponin I slow enhancer. Journal of Biological Chemistry, 278(38), 36603-36619.
  • Tay, E., Guven, K., Subramaniam, N., Polly, P., Issa, L., Gunning, P., Hardeman, E. (2003). Regulation of alternative splicing of Gtf2ird1 and its impact on slow muscle proomoter activity. Biochemical Journal, 374(2), 359-367.

To update your profile click here. For support on your academic profile contact .